Blog - Archive for Fraud Investigation

A Fraudulent Nursing Diploma Scheme Results in Federal Charges Against 25; DOH Rolls Out Enforcement Action Against Nursing Students

Posted on Firm News, Fraud Investigation, Health Care Law News, Professional Licensure Investigations, Uncategorized February 28, 2023 by Parker Eastin

The U.S. Attorney’s office for the Southern District of Florida has announced its pursuit of a fraudulent scheme whereby the administrators of three Florida nursing schools, along with employees at several nursing test prep academies in other states allegedly “created an illegal licensing and employment shortcut for aspiring nurses.” The scheme involved the selling of Read more →

Tags :

CMS Recently Proposed Important Change to 60-Day Overpayment Refund Rule

Posted on Fraud Investigation, Health Care Law News, Medicare Reimbursement February 27, 2023 by Erin Ferber

CMS recently proposed a revision to the 60-day overpayment rule that would impact Medicare participating providers and entities. Generally speaking, a provider must return an overpayment within 60-days after the date on which the overpayment was identified.  A person has identified an overpayment when the person has, or should have through the exercise of reasonable Read more →

Tags :

Deputy Attorney General Announces Significant Changes to DOJ Policies Regarding Corporate Investigations and Voluntary Self-Disclosure Incentives

Posted on Fraud Investigation, Health Care Law News October 7, 2022 by Rachel Broughton

On September 15, 2022, Deputy Attorney General Lisa Monaco published a memorandum which laid out the Department of Justice’s (DOJ) new guidelines for policies regarding corporate investigations and voluntary self-disclosures. The DOJ announced it would expand and/or clarify its policies on voluntary self-disclosure, making it its goal to reward companies that have invested in compliance Read more →

Tags :

US DOJ Announces Criminal Charges for $1.2 Billion in Telemedicine, Cardiovascular and Cancer Genetic Testing and DME Fraud

Posted on Fraud Investigation, Health Care Law News July 21, 2022 by Rachel Broughton

On Wednesday, July 20, 2022, the United States Department of Justice (DOJ) announced criminal charges against 36 defendants in 13 federal districts across the United States for more than $1.2 billion in alleged fraudulent telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment (DME) schemes. In connection with the enforcement action, the department seized Read more →

Tags :

Navigating the Broad Implications of EKRA in the Substance Abuse and Diagnostic Laboratory Testing Industries

Posted on Fraud Investigation, Health Care Law News July 19, 2022 by Rachel Broughton

The Eliminating Kickbacks in Recovery Act, otherwise known as EKRA, is a fairly new federal law that targets patient brokering and recovery profiteering. EKRA broadly makes it a federal crime for anyone, with respect to services covered by any health care benefit program, to knowingly and willfully: solicit or receive any remuneration (including any kickback, Read more →

Tags : , , ,